Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rufinamide in Refractory Partial Seizures
NCT00334958Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2006
- Primary completion
- May 2009
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of rufinamide in epilepsy, sponsored by Eisai Co., Ltd.. Started Feb 2006; status: completed.
02
Drugs
rufinamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00334958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334958.